Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Correlate Infrastructure Partners Inc. (CIPI) Puts Profits in Positive Territory, Discusses ‘Very Aggressive’ Plan For Clean Energy Solutions Projects

Commercial clean energy solutions provider Correlate Infrastructure Partners recently released its annual financial report, showing profits rising into positive territory on the back of key acquisitions last year Correlate’s development and finance platform services are designed to help buildings reduce their carbon footprint through greater efficiency and access to locally sited solar, energy storage and […]

Knightscope, Inc. (NASDAQ: KSCP) Helping Companies Secure Critical Infrastructure, Reduce Security Threats

Knightscope develops Autonomous Security Robots (“ASRs”) that combine artificial intelligence (“AI”), robotics, and self-driving technology The company’s ASRs are used by clients operating in various industries, including critical infrastructure sectors such as public utilities, food and healthcare The robots have helped reduce crime/security threats in different neighborhoods, cities, and commercial facilities Every November, the Cybersecurity […]

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Driving the Psychedelic Conversation Forward Through Education, Research, and Service Delivery

Delic is committed to bringing science-backed benefits to as many people as possible while also changing the narrative around psychedelics It seeks to achieve this through education, products and services, and research on psychedelics So far, LSD and psilocybin have proven to reduce end of life (“EOL”) anxiety for terminally ill patients Delic recognizes the […]

DGE 6th Virtual Clinical Trial Conference To Share Insights On Reducing Patient Burden and Trial Cost

The 6th Virtual Clinical Trial Conference, a trusted conference on decentralized trials, invites professionals, clinicians, and vendors of the pharma, medical device, and biotech fields. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The global event company focuses on meeting the dynamic informational and networking needs of […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH

Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugs This becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S. It adds to the company’s growing patent portfolio, which also consists of ~50 pending patents worldwide Over the 2022 calendar year, the company seeks […]

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2

Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in Michigan The debut marks the company’s entry into the live resin in Michigan, which yield higher margins than the company’s existing distillate vape products RWB expects to release its full-year 2021 results on […]

​A History of Catchphrases: InnerScope Hearing Technologies Inc. (INND) Aiming to Become the Next Lifelin

Once ignored by investors and known mostly for its catchphrase treated as a punchline, Lifeline eventually sold to Royal Philips Electronics for $690 million InnerScope Hearing Technologies is making its presence known in the affordable hearing aid market, including a memorable commercial and a rapidly expanding list of physical and online retailers InnerScope is expanding […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Preclinical Data from CYB004 Study Showing Significant Advantages

Earlier studies show that CYB004 via inhalation may solve existing challenges and support a clinical path forward for this important therapeutic Cybin is currently developing CYB004 for the treatment of anxiety disorders The new chemical entity is covered by a patent issued earlier this year Cybin (NEO: CYBN) (NYSE American: CYBN) has released data from a […]

 

From Our Blog

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Marks a Strategic Inflection Point with $7,800,421 in Total Financing Following Closing of LIFE, Flow Through, and Final Hard Dollar Offering

January 9, 2026

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is a Canadian gold exploration and development company advancing its district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production […]

Rotate your device 90° to view site.